Time for India to be firm with drugmakers rather than deregulate

Lax stance risks opportunity for 'friend-shoring' to serve Western nations

Avatar
20230131 Serum Institute of India.jpg

Employees pack boxes containing vials of Covishield coronavirus vaccine at the Serum Institute of India in Pune in November 2021: New Delhi should seek to amend the constitution and consolidate drug regulation at a national level.  © AP

Akhil Ramesh is a research fellow at the Pacific Forum, a foreign policy research institute based in Honolulu, Hawaii.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.